
==== Front
World J Psychiatry
WJP
World Journal of Psychiatry
2220-3206
Baishideng Publishing Group Inc

jWJP.v14.i9.pg1411
10.5498/wjp.v14.i9.1411
94635
Letter to the Editor
Burdened breaths: The influence of depression on obstructive sleep apnea
Wang X et al. Depression and obstructive sleep apnea
Wang Xiao The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, Gansu Province, China

Song Shao-Ming The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, Gansu Province, China

Yue Hong-Mei The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, Gansu Province, China. yhmlcsy@163.com

Author contributions: Wang X and Yue HM designed the study; Song SM searched the literature; Wang X and Yue HM wrote the manuscript; All authors approved the final manuscript.

Corresponding author: Hong-Mei Yue, MD, PhD, Doctor, Professor, The First School of Clinical Medicine, Lanzhou University, No. 199 West Donggang Road, Lanzhou 730000, Gansu Province, China. yhmlcsy@163.com

19 9 2024
19 9 2024
14 9 14111414
21 3 2024
7 8 2024
13 8 2024
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
2024
https://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
Depression and metabolic syndrome could exacerbate the risks of the other, leading to a series of severe coexisting conditions. One notable comorbidity that must be mentioned is obstructive sleep apnea (OSA). Current studies suggested that depression increases susceptibility to OSA. As the prevalence of depression rises, it becomes critical to prevent and manage its complications or comorbidities, including OSA. Predictive models, non-invasive electroencephalogram monitoring, genetic research, and other promising technologies are being applied to the prevention, diagnosis, and personalized treatment of depression and OSA.

Depression
Obstructive sleep apnea
Metabolic syndrome
Prevalence
Risk factor
==== Body
pmc Core Tip: Depression and obstructive sleep apnea frequently coexist and share similar symptoms. By exploring the causal relationship between depression and obstructive sleep apnea, we may gain new insights and develop strategies for their prevention and treatment, contributing to improved overall health status for these patients and promoting the development of personalized treatment approaches.

TO THE EDITOR

We read the retrospective cohort study published by Zhou et al[1] in the World Journal of Psychiatry in 2024. This study investigated the incidence and risk factors of depression among patients with metabolic syndrome (MetS). Subsequently, data from the 2-year, 4-year, and 7-year follow-up were analyzed to construct a predictive model for depression in patients with MetS. According to currently available studies, there is a strong relationship between depression and MetS. Zhou et al[1] described the causes and potential mechanisms associated with MetS and depression, and we believe that these results provide some insight into the causality of MetS and depression. However, the causality and direction of the two remains unclear due to the shortcomings of current observational study designs and the low feasibility of implementing randomized controlled trials[2,3].

Studies have shown that patients with depression were more likely to become obese or suffer from MetS due to lifestyle changes, sleep disorders, chronic inflammation, and the side effects of psychotropic medications[4,5]. Similarly, inflammation, imbalances in the neuroendocrine system, increased societal stress, poor lifestyle, and long-term medication render patients with MetS more susceptible to depression[6,7]. This suggests that the two conditions can exacerbate the risks of the other and lead to a series of severe coexisting diseases. One notable comorbidity that must be mentioned is obstructive sleep apnea (OSA)[8]. OSA is a common sleep disorder characterized by repeated episodes of upper airway collapse or obstruction, resulting in reduced or complete cessation of airflow during sleep[9]. OSA significantly affects sleep quality and physical health, leading to physical impairments and socioeconomic burdens. Long-term OSA increases the risk of heart disease, high blood pressure, and stroke[10,11].

Many studies have reported a strong association between depression and OSA, but most have focused on investigating the prevalence of depression among patients with OSA[12-16]. Using mendelian randomization analyses, our previously published study provided preliminary evidence that depression increases susceptibility to OSA[17]. Analyzing changes in nocturnal plasma levels of free fatty acids, glucose, and cortisol in patients with OSA, Chopra et al[18] found that patients with OSA and depression share increased sensitivity to corticotropin-releasing hormone, glucocorticoid resistance, and elevated cortisol levels due to similar hyperactivity of the hypothalamic-pituitary-adrenal axis and sympathetic nervous system. Furthermore, both depression and OSA have been shown to be associated with chronic inflammation and are characterized by higher levels of proinflammatory cytokines such as tumor necrosis factor-alpha and interleukin-6[19,20].

Overall, the pathophysiological mechanisms of how depression contributes to OSA are not fully understood, but they may be related to several potential mechanisms as follows. Lifestyle and circadian rhythm changes could cause disruptions in sleep-wake rhythms, affecting the physiological balance of sleep and wake functions[21-23]. Depression is typically accompanied by hyperactivation of the hypothalamic-pituitary-adrenal axis; as adrenocorticotropic hormone secretion increases, patients may experience a decrease in slow-wave sleep duration and an increase in the average number of awakenings[24]. Moreover, impairment of the central and peripheral 5-hydroxytryptamine systems could affect airway patency. Reduced 5-hydroxytryptamine levels are thought to be one of the critical mechanisms leading to upper airway collapse and potentially to OSA[25].

As the prevalence of depression increases, it becomes critical to prevent and manage its complications or comorbidities such as OSA. Depression and OSA often coexist and exhibit similar symptoms, such as poor concentration, memory loss, mood swings, and unusual fatigue, which can complicate the clinical diagnosis of both conditions. Zhou et al[1] investigated the prevalence and risk factors of depression in patients with MetS and constructed predictive models through a large-sample cohort study. We believe this has significant implications, but there is no such model to predict the occurrence of OSA in depressed patients. For depressed patients, non-invasive electroencephalogram to detect susceptibility to OSA is a powerful tool[26]. Exploring the comorbidity and correlation between OSA and depression and understanding the prevalence in different populations could help identify high-risk groups and facilitate early intervention.

The treatment of OSA comorbid with depressive disorders involves various therapies for depression, including pharmacological and non-pharmacological interventions such as light therapy, sleep deprivation, and rhythm therapy. They have been shown to affect circadian rhythms. Oxidative stress and inflammation can also disrupt sleep architecture, contributing to dysfunctional sleep patterns[27]. As the first-line treatment for OSA, studies have shown that continuous positive airway pressure therapy could improve depressive symptoms in patients over the long term, despite the presence of high heterogeneity. As more and more promising technologies are applied to depression and OSA, there will be opportunities to enhance our understanding of them and other comorbidities. The potential mechanisms may provide new ideas and strategies for the prevention and treatment of OSA and depression and help improve the overall health of such patients. However, current evidence largely depends on cross-sectional clinical data and a limited number of experimental results, which challenges the assertion that depression explicitly causes OSA.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Provenance and peer review: Invited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Psychiatry

Country of origin: China

Peer-review report’s classification

Scientific Quality: Grade C

Novelty: Grade B

Creativity or Innovation: Grade B

Scientific Significance: Grade B

P-Reviewer: Zhang YH S-Editor: Li L L-Editor: Filipodia P-Editor: Cai YX
==== Refs
1 Zhou LN Ma XC Wang W Incidence and risk factors of depression in patients with metabolic syndrome World J Psychiatry 2024 14 245 254 38464768
2 Repousi N Masana MF Sanchez-Niubo A Haro JM Tyrovolas S Depression and metabolic syndrome in the older population: A review of evidence J Affect Disord 2018 237 56 64 29772477
3 Dekker IP Marijnissen RM Giltay EJ van der Mast RC Oude Voshaar RC Rhebergen D Rius Ottenheim N The role of metabolic syndrome in late-life depression over 6 years: The NESDO study J Affect Disord 2019 257 735 740 31386966
4 Hiles SA Révész D Lamers F Giltay E Penninx BW Bidirectional Prospective Associations of Metabolic Syndrome Components with Depression, Anxiety, And Antidepressant Use Depress Anxiety 2016 33 754 764 27120696
5 Sekita A Arima H Ninomiya T Ohara T Doi Y Hirakawa Y Fukuhara M Hata J Yonemoto K Ga Y Kitazono T Kanba S Kiyohara Y Elevated depressive symptoms in metabolic syndrome in a general population of Japanese men: a cross-sectional study BMC Public Health 2013 13 862 24044502
6 García-Toro M Vicens-Pons E Gili M Roca M Serrano-Ripoll MJ Vives M Leiva A Yáñez AM Bennasar-Veny M Oliván-Blázquez B Obesity, metabolic syndrome and Mediterranean diet: Impact on depression outcome J Affect Disord 2016 194 105 108 26807670
7 Moazzami K Lima BB Sullivan S Shah A Bremner JD Vaccarino V Independent and joint association of obesity and metabolic syndrome with depression and inflammation Health Psychol 2019 38 586 595 31120270
8 Lv R Liu X Zhang Y Dong N Wang X He Y Yue H Yin Q Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome Signal Transduct Target Ther 2023 8 218 37230968
9 Lévy P Kohler M McNicholas WT Barbé F McEvoy RD Somers VK Lavie L Pépin JL Obstructive sleep apnoea syndrome Nat Rev Dis Primers 2015 1 15015 27188535
10 Sabil A Gagnadoux F Obstructive sleep apnoea, nocturnal hypoxaemia, and cognitive decline in elderly patients Eur Respir J 2023 61
11 Martinez-Garcia MA Campos-Rodriguez F Gozal D Obstructive sleep apnoea in acute coronary syndrome Lancet Respir Med 2020 8 e15 32035024
12 Fang H Tu S Sheng J Shao A Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment J Cell Mol Med 2019 23 2324 2332 30734486
13 Gleeson M McNicholas WT Bidirectional relationships of comorbidity with obstructive sleep apnoea Eur Respir Rev 2022 31
14 Chen YH Keller JK Kang JH Hsieh HJ Lin HC Obstructive sleep apnea and the subsequent risk of depressive disorder: a population-based follow-up study J Clin Sleep Med 2013 9 417 423 23674930
15 Lu MK Tan HP Tsai IN Huang LC Liao XM Lin SH Sleep apnea is associated with an increased risk of mood disorders: a population-based cohort study Sleep Breath 2017 21 243 253 27495797
16 Lee SA Paek JH Han SH REM-related sleep-disordered breathing is associated with depressive symptoms in men but not in women Sleep Breath 2016 20 995 1002 26969657
17 Wang X Song S Dong N Lv R He Y Zhao Y Yue H The causal relationship between depression and obstructive sleep apnea: A bidirectional Mendelian randomization study J Psychosom Res 2024 179 111620 38430795
18 Chopra S Rathore A Younas H Pham LV Gu C Beselman A Kim IY Wolfe RR Perin J Polotsky VY Jun JC Obstructive Sleep Apnea Dynamically Increases Nocturnal Plasma Free Fatty Acids, Glucose, and Cortisol During Sleep J Clin Endocrinol Metab 2017 102 3172 3181 28595341
19 Gaines J Vgontzas AN Fernandez-Mendoza J Kritikou I Basta M Bixler EO Gender differences in the association of sleep apnea and inflammation Brain Behav Immun 2015 47 211 217 25535861
20 Goldsmith DR Rapaport MH Miller BJ A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression Mol Psychiatry 2016 21 1696 1709 26903267
21 Gupta MA Simpson FC Lyons DC The effect of treating obstructive sleep apnea with positive airway pressure on depression and other subjective symptoms: A systematic review and meta-analysis Sleep Med Rev 2016 28 55 68 26454823
22 Holma IA Holma KM Melartin TK Ketokivi M Isometsä ET Depression and smoking: a 5-year prospective study of patients with major depressive disorder Depress Anxiety 2013 30 580 588 23606190
23 Pandi-Perumal SR Monti JM Burman D Karthikeyan R BaHammam AS Spence DW Brown GM Narashimhan M Clarifying the role of sleep in depression: A narrative review Psychiatry Res 2020 291 113239 32593854
24 Eser D Schüle C Romeo E Baghai TC di Michele F Pasini A Zwanzger P Padberg F Rupprecht R Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders Psychopharmacology (Berl) 2006 186 373 387 16247651
25 Liu C Meng Z Wiggin TD Yu J Reed ML Guo F Zhang Y Rosbash M Griffith LC A Serotonin-Modulated Circuit Controls Sleep Architecture to Regulate Cognitive Function Independent of Total Sleep in Drosophila Curr Biol 2019 29 3635 3646.e5 31668619
26 de Aguiar Neto FS Rosa JLG Depression biomarkers using non-invasive EEG: A review Neurosci Biobehav Rev 2019 105 83 93 31400570
27 Farney RJ Lugo A Jensen RL Walker JM Cloward TV Simultaneous use of antidepressant and antihypertensive medications increases likelihood of diagnosis of obstructive sleep apnea syndrome Chest 2004 125 1279 1285 15078735
